J 861
Latest Information Update: 23 Mar 2007
At a glance
- Originator Jenapharm
 - Class
 - Mechanism of Action Antioxidants; Estrogen receptor agonists; Free radical scavengers
 
- 
          
            
              Orphan Drug Status
              No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
 - New Molecular Entity Yes
 
Highest Development Phases
- Discontinued Menopausal syndrome
 
Most Recent Events
- 20 May 2003 Preclinical trials in Menopausal syndrome in Germany (unspecified route)